With Prasad's Return to the FDA, Capricor is Set to Challenge CRL for DMD-Related Cardiomyopathy

With Prasad’s Return to the FDA, Capricor is Set to Challenge CRL for DMD-Related Cardiomyopathy

With Prasad's Return to the FDA, Capricor is Set to Challenge CRL for DMD-Related Cardiomyopathy